Inogen, Inc., established in 2001, is a leading global medical technology company specializing in innovative respiratory products for homecare settings. The company develops, manufactures, and markets portable oxygen concentrators (POCs) designed to deliver oxygen therapy to patients with chronic respiratory conditions.
Inogen’s product line includes several models of portable oxygen concentrators, such as the Inogen One G5, G4, and G3 systems, as well as the Rove 4 and Rove 6 systems. These devices are designed to provide patients with reliable and efficient oxygen therapy, promoting mobility and independence.
The company emphasizes the importance of clinical evidence in supporting the use of its oxygen therapy devices. Inogen has completed and published numerous reports focused on clinical data supporting its oxygen concentrators, underscoring its commitment to evidence-based healthcare solutions.
Inogen’s products are distributed and used throughout the world, with a global presence that includes international distributors in the United States, Europe, Mexico, Singapore, India, Australia, New Zealand, and more. This extensive distribution network enables Inogen to serve a diverse patient population across various regions.